Anixa Biosciences, Inc. (ANIX)
USD 2.74
(-0.55%)
USD 2.74
(-0.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 210 Thousand | 2.46 Billion | 512.5 Thousand | - | 250 Thousand | 1.11 Million |
| Cost of Revenue | 161 Thousand | 42 Thousand | 385 Thousand | 90.15 Thousand | 166.25 Thousand | 768.41 Thousand |
| Gross Profit | 49 Thousand | 2.46 Billion | 127.49 Thousand | -90.15 Thousand | 83.75 Thousand | 344.09 Thousand |
| Operating Expenses | 11.06 Million | 13.87 Million | 13.26 Million | 9.97 Million | 11.55 Million | 14.05 Million |
| Selling, General and Administrative Expenses | 6.29 Million | 7.17 Million | 7.07 Million | 5.59 Million | 5.66 Million | 6.91 Million |
| Research and Development Expenses | 4.76 Million | 6.7 Million | 6.18 Million | 4.38 Million | 5.47 Million | 6.81 Million |
| Other Expenses | - | - | - | - | 418.75 Thousand | - |
| Cost and Expenses | 11.22 Million | 13.87 Million | 13.64 Million | 9.97 Million | 11.72 Million | 14.81 Million |
| Operating Income | -11.01 Million | -13.87 Million | -13.13 Million | -9.97 Million | -11.47 Million | -14.28 Million |
| Interest Expense | - | 104 Thousand | 322.00 | - | - | - |
| Income Tax Expense | - | -280 Thousand | -181.29 Thousand | 40.15 Thousand | 175.79 Thousand | 289.94 Thousand |
| Earnings before Tax | -9.93 Million | -13.77 Million | -13.12 Million | -10.09 Million | -11.81 Million | -14.24 Million |
| Net Income | -9.81 Million | -13.49 Million | -12.94 Million | -10.13 Million | -11.99 Million | -13.99 Million |
| Earnings Per Share Basic | -0.32 | -0.44 | -0.45 | -0.46 | -0.61 | -0.79 |
| Earnings Per Share Diluted | -0.32 | -0.44 | -0.45 | -0.46 | -0.61 | -0.79 |
| Weighted Average Shares Outstanding | 30.98 Million | 30.37 Million | 28.57 Million | 22.22 Million | 19.78 Million | 17.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.98 Million | 30.37 Million | 28.57 Million | 22.22 Million | 19.78 Million | 17.62 Million |
| Gross Margin | 0.23 | 1.00 | 0.25 | - | 0.34 | 0.31 |
| EBIT Margin | -52.21 | -0.01 | -25.52 | - | -42.34 | -11.49 |
| Profit Margin | -46.72 | -0.01 | -25.26 | - | -47.98 | -12.58 |
| EBITDA | -10.96 Million | -13.72 Million | -13.08 Million | -10 Million | -11 Million | -13.36 Million |
| Earnings Before Tax Margin | -52.43 | -0.01 | -25.63 | - | -45.89 | -12.84 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 156 Thousand | 210 Thousand | - |
| Cost of Revenue | 3000.00 | 12 Thousand | 13 Thousand | 12 Thousand | 161 Thousand | 11 Thousand |
| Gross Profit | -3000.00 | -12 Thousand | -13 Thousand | 144 Thousand | 49 Thousand | -11 Thousand |
| Operating Expenses | 3.58 Million | 3.45 Million | 3.59 Million | 3.05 Million | 11.06 Million | 2.84 Million |
| Selling, General and Administrative Expenses | 1.66 Million | 1.8 Million | 2.24 Million | 1.43 Million | - | 1.75 Million |
| Research and Development Expenses | 1.92 Million | 1.64 Million | 1.34 Million | 1.61 Million | - | 1.08 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.59 Million | 3.46 Million | 3.6 Million | 3.05 Million | 11.22 Million | 2.84 Million |
| Operating Income | -3.59 Million | -3.46 Million | -3.6 Million | -3.05 Million | -11.01 Million | -2.84 Million |
| Interest Expense | - | - | - | 51 Thousand | - | - |
| Income Tax Expense | -38 Thousand | -41 Thousand | -35 Thousand | -31 Thousand | -119 Thousand | -37 Thousand |
| Earnings before Tax | -3.31 Million | -3.18 Million | -3.29 Million | -2.72 Million | -9.93 Million | -2.54 Million |
| Net Income | -3.27 Million | -3.13 Million | -3.25 Million | -2.69 Million | -9.81 Million | -2.51 Million |
| Earnings Per Share Basic | -0.10 | -0.10 | -0.10 | -0.09 | - | -0.08 |
| Earnings Per Share Diluted | -0.10 | -0.10 | -0.10 | -0.09 | - | -0.08 |
| Weighted Average Shares Outstanding | 32.05 Million | 31.91 Million | 31.44 Million | 31.08 Million | 30.98 Million | 30.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.05 Million | 31.91 Million | 31.44 Million | 31.08 Million | 30.98 Million | 30.97 Million |
| Gross Margin | - | - | - | 0.92 | 0.23 | - |
| EBIT Margin | - | - | - | -19.48 | - | - |
| Profit Margin | - | - | - | -17.24 | -46.72 | - |
| EBITDA | -3.58 Million | -3.45 Million | -3.59 Million | -3.03 Million | - | -2.83 Million |
| Earnings Before Tax Margin | - | - | - | -19.56 | -52.43 | - |
GBNY
SEACOAST
NTCT
1443
LHA
FMCKN